Showing results (21-30 of 523) with videos related to

Sort By:
Pageof 53
Annals of Neurology|January 1, 1996
Relationship between trinucleotide repeats and neuropathological changes in Huntington's diseaseS Furtado, O Suchowersky, B Rewcastle, et al.
Neurology|April 12, 2006
Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) [RETIRED]: report of the Quality Standards Subcommittee of the American Academy of NeurologyO Suchowersky, S Reich, J Perlmutter, et al.
Neurology|January 10, 2002
Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review [RETIRED]: report of the Quality Standards Subcommittee of the American Academy of NeurologyJ M Miyasaki, W Martin, O Suchowersky, et al.
Neurology|April 12, 2006
Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyO Suchowersky, G Gronseth, J Perlmutter, et al.
The American Journal of Medicine|January 1, 1982
Dialysis encephalopathy and osteomalacic bone disease: a case-controlled studyJ C Prior, E C Cameron, W J Knickerbocker, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year periodG-Y R Hsiung, S K Das, R Ranawaya, et al.
Canadian Family Physician Medecin De Famille Canadien|January 22, 2011
Predictive medicine: recombinant DNA technology and adult-onset genetic disordersM Hayden
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 28, 1978
The fetal hydantoin syndrome. A case reportM Hayden
Neurology|April 1, 1997
Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study GroupI H Richard, R Kurlan, C Tanner, et al.
Clinical Neuropharmacology|July 15, 2000
The relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's diseaseD J Chong, O Suchowersky, C Szumlanski, et al.
Pageof 53